Cell based skin subs for definitive care of burn injuries

Ended Definitive Contract Awarded Last action

Contract number
HHSO100201500027C
Awardee
Awarding agency
Obligated
$75,284,563

Award facts

Opportunity
Contract value 32% obligated
  • $75,284,562.70 Current, with exercised options
  • $235,674,165.70 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Madison, WI 53719, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00011 $432,810
Change Order P00010 -$29,529,101
Change Order P00009 $3,988,033
Supplemental Agreement for work within scope P00008 $0
Change Order P00007 · The purpose of this modification is to update article B.3. Option prices, C.1 statement of work, G.1 contracting officer, and G.3 key personnel. Funds obligated… $2,457,194
Other Administrative Action P00006 · The purpose of this modification is to update article B.5. Advance understandings, F.3 deliveries, G.1 contracting officer, G.2 contracting officer?S… $0
Other Administrative Action P00005 · The purpose of this modification is to update article B.2. Article C.1.and article G.3. See attached. $11,595,994
Exercise an Option 4 $26,341,606
Change Order 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $59,998,027
Show all 12

About this award

Written by GovTribe AI ·

This is a federal contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Stratatech Corporation, a subsidiary of the global pharmaceutical company Mallinckrodt Plc. The $235,674,165.70 cost-plus-fixed-fee contract, awarded on September 29, 2015, is for the development of cell-based skin substitutes for the definitive care of burn injuries. The contract has a completion date of September 28, 2025. Stratatech Corporation is a foreign-owned, for-profit organization that has previously received federal grant funding for the development of regenerative medicine and tissue engineering products. This contract does not have a set-aside designation. In addition to this contract award, Stratatech Corporation also holds two active federal Indefinite Delivery Vehicle (IDV) contracts with the Department of Veterans Affairs to provide pharmaceutical and hematology-related products to VA medical facilities.

Quick answers

Who was awarded contract HHSO100201500027C?

HHSO100201500027C was awarded to Stratatech Corporation by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 29, 2015.

How much is contract HHSO100201500027C worth?

The government has obligated $75,284,563 on HHSO100201500027C. Its potential value, with all options, is $235,674,166.

Was contract HHSO100201500027C competed?

The extent of competition for HHSO100201500027C was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login